Cases of botulism tied to ByHeart baby formula have doubled since the company expanded its recall of the products early this month, according to the U.S. Food and Drug Administration. There are now at least 31 reported cases of infant botulism associated with various lots of the ByHeart Whole Nutrition infant formula, the FDA said Wednesday. The infants were hospitalized across 15 states since Aug. 9, with the most recent case reported on Nov. 13, but no deaths have been reported.
Main Idea: The FDA says botulism cases tied to ByHeart baby formula have risen to 31 as the company’s recall continues and the product is still being found in stores.
Key Points:
The ByHeart recall may leave parents worried about infant formula safety, and babies exposed to the product can face serious illness, hospital care, or worse.
FDA warnings and store checks may help families and stores remove risky formula faster.
Rate how each entity in this article affected the American people.
Central company behind the recalled infant formula and the subject of the lawsuits and FDA recall coverage.
Specific recalled product tied directly to the outbreak and consumer warnings.
Main regulator issuing the recall update, reporting case counts, and warning consumers.
Named parent quoted about the outbreak and the family’s experience, but not a central decision-maker.
Editorial credit only, not part of the article’s substantive focus.
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to comment